Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States
- 4 August 2022
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (5) , 1281-1292.e10
Abstract
No abstract availableKeywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RP200633)
- National Institutes of Health (R01 MD012565)
- National Institutes of Health (R01CA256977)
This publication has 44 references indexed in Scilit:
- Referral Patterns and Treatment Choices for Patients with Hepatocellular Carcinoma: A United States Population-Based StudyJournal of the American College of Surgeons, 2013
- Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United StatesAlimentary Pharmacology & Therapeutics, 2013
- Delay in Surgical Treatment and Survival After Breast Cancer Diagnosis in Young Women by Race/EthnicityJAMA Surgery, 2013
- Socioeconomic Status and Hepatocellular Carcinoma in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2012
- Diagnostic interval and mortality in colorectal cancer: U-shaped association demonstrated for three different datasetsJournal of Clinical Epidemiology, 2012
- Introduction: Understanding and Influencing Multilevel Factors Across the Cancer Care ContinuumJournal of the National Cancer Institute Monographs, 2012
- Landmark Analysis at the 25-Year Landmark PointCirculation: Cardiovascular Quality and Outcomes, 2011
- Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: Is there a lead-time bias?Scandinavian Journal of Gastroenterology, 2007
- Disparities Despite CoverageArchives of internal medicine (1960), 2005
- Who You Are And Where You Live: How Race And Geography Affect The Treatment Of Medicare BeneficiariesHealth Affairs, 2004